These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34807468)

  • 21. Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies.
    Tsimafeyeu I; Volkova M; Alekseeva G; Berkut M; Nosov A; Myslevtsev I; Andrianov A; Semenov A; Borisov P; Zukov R; Goutnik V; Savchuk S; Dengina N; Mitin T
    J Hematol Oncol; 2021 Nov; 14(1):192. PubMed ID: 34774086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia.
    Guisado-Vasco P; Carralón-González MM; Aguareles-Gorines J; Martí-Ballesteros EM; Sánchez-Manzano MD; Carnevali-Ruiz D; García-Coca M; Barrena-Puertas R; de Viedma RG; Luque-Pinilla JM; Sotres-Fernandez G; Fernández-Sousa JM; Luepke-Estefan XE; López-Martín JA; Jimeno JM
    J Hematol Oncol; 2022 Jan; 15(1):4. PubMed ID: 35012608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 vs smallpox: mass vaccinations in the mirror.
    Bianucci R; Nerlich AG; Cigliuti E; Donell ST; Perciaccante A
    Intern Emerg Med; 2021 Oct; 16(7):2031-2034. PubMed ID: 33847903
    [No Abstract]   [Full Text] [Related]  

  • 24. Cryptococcosis: an unusual opportunistic infection complicating B cell lymphoproliferative disorders.
    Melzer M; Colbridge M; Keenan F; Stainsby D; Ong EL
    J Infect; 1998 Mar; 36(2):220-2. PubMed ID: 9570659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-protective immunity following coronavirus vaccination and coronavirus infection.
    Dangi T; Palacio N; Sanchez S; Park M; Class J; Visvabharathy L; Ciucci T; Koralnik IJ; Richner JM; Penaloza-MacMaster P
    J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34623973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Migraine treatment and COVID-19 vaccines: No cause for concern.
    Gelfand AA; Poland G
    Headache; 2021 Mar; 61(3):409-411. PubMed ID: 33543775
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple brain tumors of diffuse large B cell lymphoma in a patient with Waldenström's macroglobulinemia/ lymphoplasmacytic lymphoma: PCR and DNA sequence analysis show evidence of differences in clonality of the two B cell malignancies.
    Tojo K; Hattori T; Ito T; Asano N; Sano K; Suzuki T; Maruyama K
    Intern Med; 2004 Oct; 43(10):990-6. PubMed ID: 15575254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 vaccination should be required to practise medicine in Canada.
    McRae AD; Laupacis A
    CMAJ; 2021 Nov; 193(47):E1816-E1817. PubMed ID: 34753806
    [No Abstract]   [Full Text] [Related]  

  • 29. Malignant lymphoma, well differentiated lymphocytic: its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenström.
    Pangalis GA; Nathwani BN; Rappaport H
    Cancer; 1977 Mar; 39(3):999-1010. PubMed ID: 410498
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19 vaccines and decreased transmission of SARS-CoV-2.
    Vitiello A; Ferrara F; Troiano V; La Porta R
    Inflammopharmacology; 2021 Oct; 29(5):1357-1360. PubMed ID: 34279767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
    Cuneo A; Rigolin GM; Coscia M; Quaresmini G; Scarfò L; Mauro FR; Motta M; Quaglia FM; Trentin L; Ferrario A; Laurenti L; Reda G; Ferrari A; Pietrasanta D; Sportoletti P; Re F; De Paoli L; Foglietta M; Giordano A; Marchetti M; Farina L; Del Poeta G; Varettoni M; Chiurazzi F; Marasca R; Malerba L; Ibatici A; Tisi MC; Stefoni V; Leone M; Baratè C; Olivieri J; Murru R; Gentile M; Sanna A; Gozzetti A; Gattei V; Gottardi D; Derenzini E; Levato L; Orsucci L; Penna G; Chiarenza A; Foà R
    Hematol Oncol; 2021 Oct; 39(4):570-574. PubMed ID: 34258787
    [No Abstract]   [Full Text] [Related]  

  • 32. Trajectory of COVID-19 Vaccine Hesitancy Over Time and Association of Initial Vaccine Hesitancy With Subsequent Vaccination.
    Siegler AJ; Luisi N; Hall EW; Bradley H; Sanchez T; Lopman BA; Sullivan PS
    JAMA Netw Open; 2021 Sep; 4(9):e2126882. PubMed ID: 34559232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary lung involvement with amyloid deposition in Waldenstöm's macroglobulinemia: observations from over 20 years.
    Okuda M; Okuda Y; Ogura T; Kashio M; Masuno T; Oji Y; Miyazaki M
    Respirology; 2004 Aug; 9(3):414-8. PubMed ID: 15497253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: one disease or three?
    Kraus MD
    Am J Clin Pathol; 2001 Dec; 116(6):799-801. PubMed ID: 11764065
    [No Abstract]   [Full Text] [Related]  

  • 35. Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients.
    Gundavda MK; Gundavda KK
    Curr Treat Options Oncol; 2021 Sep; 22(10):95. PubMed ID: 34515857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trend in COVID-19 vaccination among people with diabetes: A short study from India.
    Nachimuthu S; Viswanathan V
    Diabetes Metab Syndr; 2021; 15(4):102190. PubMed ID: 34245963
    [No Abstract]   [Full Text] [Related]  

  • 37. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia associated with Hodgkin disease. A report of two cases.
    Rosales CM; Lin P; Mansoor A; Bueso-Ramos C; Medeiros LJ
    Am J Clin Pathol; 2001 Jul; 116(1):34-40. PubMed ID: 11447749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases.
    Felten R; Dubois M; Ugarte-Gil MF; Chaudier A; Kawka L; Bergier H; Costecalde C; Pijnenburg L; Fort J; Chatelus E; Sordet C; Javier RM; Gottenberg JE; Sibilia J; Fuentes-Silva YJ; Arnaud L
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI68-SI76. PubMed ID: 33983432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 vaccines for patients with haematological conditions.
    Sun C; Pleyer C; Wiestner A
    Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
    [No Abstract]   [Full Text] [Related]  

  • 40. DC-based immunotherapy of B-cell malignancies.
    Reichardt VL; Brossart P
    Cytotherapy; 2004; 6(1):62-7. PubMed ID: 14985168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.